Combinatorial synthesis of CCR5 antagonists

被引:41
作者
Willoughby, CA [1 ]
Berk, SC
Rosauer, KG
Degrado, S
Chapman, KT
Gould, SL
Springer, MS
Malkowitz, L
Schleif, WA
Hazuda, D
Miller, M
Kessler, J
Danzeisen, R
Holmes, K
Lineberger, J
Carella, A
Carver, G
Emini, EA
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Immunol Res, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA
关键词
D O I
10.1016/S0960-894X(01)00652-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein we report the preparation of a combinatorial library of compounds with potent CCR5 binding affinity. The library design was aided by SAR generated in a traditional medicinal chemistry effort. Compounds with novel combinations of subunits were discovered that have high binding affinity for the CCR5 receptor. A potent CCR5 antagonist from the library, compound 11 was found to have moderate anti-HIV-1 activity. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3137 / 3141
页数:5
相关论文
共 25 条
[11]   Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 4:: Synthesis and structure-activity relationships for 1-[N(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes [J].
Finke, PE ;
Oates, B ;
Mills, SG ;
MacCoss, M ;
Malkowitz, L ;
Springer, MS ;
Gould, SL ;
DeMartino, JA ;
Carella, A ;
Carver, G ;
Holmes, K ;
Danzeisen, R ;
Hazuda, D ;
Kessler, J ;
Lineberger, J ;
Miller, M ;
Schleif, WA ;
Emini, EA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) :2475-2479
[12]   Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 2:: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl) amino]-4-(piperidin-1-yl)butanes [J].
Finke, PE ;
Meurer, LC ;
Oates, B ;
Mills, SG ;
MacCoss, M ;
Malkowitz, L ;
Springer, MS ;
Daugherty, BL ;
Gould, SL ;
DeMartino, JA ;
Siciliano, SJ ;
Carella, A ;
Carver, G ;
Holmes, K ;
Danzeisen, R ;
Hazuda, D ;
Kessler, J ;
Lineberger, J ;
Miller, M ;
Schleif, WA ;
Emini, EA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) :265-270
[13]   1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity [J].
Hale, JJ ;
Budhu, RJ ;
Holson, EB ;
Finke, PE ;
Oates, B ;
Mills, SG ;
MacCoss, M ;
Gould, SL ;
DeMartino, JA ;
Springer, MS ;
Siciliano, S ;
Malkowitz, L ;
Schleif, WA ;
Hazuda, D ;
Miller, M ;
Kessler, J ;
Danzeisen, R ;
Holmes, K ;
Lineberger, J ;
Carella, A ;
Carver, G ;
Emini, E .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) :2741-2745
[14]   1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: Discovery of the pyrrolidine scaffold and determination of its stereochemical requirements [J].
Hale, JJ ;
Budhu, RJ ;
Mills, SG ;
MacCoss, M ;
Malkowitz, L ;
Siciliano, S ;
Gould, SL ;
DeMartino, JA ;
Springer, MS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) :1437-1440
[15]   A GENERAL-METHOD FOR THE SOLID-PHASE SYNTHESIS OF UREAS [J].
HUTCHINS, SM ;
CHAPMAN, KT .
TETRAHEDRON LETTERS, 1994, 35 (24) :4055-4058
[16]   SAFETY CATCH PRINCIPLE IN SOLID PHASE PEPTIDE SYNTHESIS [J].
KENNER, GW ;
MCDERMOT.JR ;
SHEPPARD, RC .
JOURNAL OF THE CHEMICAL SOCIETY D-CHEMICAL COMMUNICATIONS, 1971, (12) :636-&
[17]  
LAUGHLIN MA, 2000, Patent No. 0066141
[18]   Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function [J].
Lee, B ;
Sharron, M ;
Blanpain, C ;
Doranz, BJ ;
Vakili, J ;
Setoh, P ;
Berg, E ;
Liu, G ;
Guy, HR ;
Durell, SR ;
Parmentier, M ;
Chang, CN ;
Price, K ;
Tsang, M ;
Doms, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9617-9626
[19]   Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil [J].
Guerra Corado, Andre de Lima ;
Villarouco da Silva, George Allan ;
Carvalho Leao, Renato Augusto ;
Granja, Fabiana ;
Naveca, Felipe Gomes .
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2016, 20 (03) :314-315
[20]   The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression [J].
Michael, NL ;
Chang, G ;
Louie, LG ;
Mascola, JR ;
Dondero, D ;
Birx, DL ;
Sheppard, HW .
NATURE MEDICINE, 1997, 3 (03) :338-340